FOLFOX regimen plus dendritic cells–cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis

PURPOSE: To systematically investigate the efficacy and safety of the combination of FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin) regimen and cocultured dendritic cells and cytokine-induced killer cells (DC-CIK) immunotherapy for the treatment of colorectal cancer (CRC). METHODS: Publication...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan, Zheng, Zhong, Zhang, Qixin, Zhou, Xinling, Feng, Yikuan, Yan, Anquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442876/
https://www.ncbi.nlm.nih.gov/pubmed/28572734
http://dx.doi.org/10.2147/OTT.S138011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442876/
https://www.ncbi.nlm.nih.gov/pubmed/28572734
http://dx.doi.org/10.2147/OTT.S138011

Ejemplares similares